Traceless protein delivery with an efficient recyclable nanocarrier
Xuanjun Wu1, Yunlong Song, Jiahuai Han
1Department of Chemical Biology, College of Chemistry and Chemical Engineering, and the Key Laboratory for Chemical Biology of Fujian Province, Xiamen University, Xiamen, China.
Biomaterials Science
|June 3, 2020
Summary
Researchers developed a vitamin B6-functionalized nanocarrier for efficient intracellular protein delivery. This bio-recyclable platform offers a traceless method for enhanced protein delivery into mammalian cells.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cell Biology
- Drug Delivery
Background:
- Intracellular delivery of pharmaceutical proteins is crucial for their therapeutic efficacy.
- Existing methods often face challenges in efficiency and potential toxicity.
- Need for advanced nanocarriers capable of safe and effective protein transport into cells.
Purpose of the Study:
- To develop and evaluate a novel bio-recyclable nanocarrier for intracellular protein delivery.
- To investigate the loading, release, and cellular uptake mechanisms of the nanocarrier.
- To compare the efficiency of this nanocarrier with established cell-penetrating peptides.
Main Methods:
- Functionalization of calcium phosphate (CP) nanocarriers with vitamin B6 (pyridoxal-5'-phosphate, PLP).
- Loading and pH-sensitive release of proteins via aldimine bond formation/hydrolysis.
- Assessment of cellular delivery efficiency in HeLa, HepG2, and L929 cell lines.
Main Results:
- PLP-CP nanocarriers successfully loaded and released proteins in a pH-sensitive manner.
- Efficient delivery of proteins into the cytosol of various mammalian cell types.
- PLP-CP mediated cell transduction was 10-40 times more efficient than the TAT peptide.
Conclusions:
- Vitamin B6-functionalized calcium phosphate (PLP-CP) serves as an effective and bio-recyclable nanocarrier.
- The PLP-CP system demonstrates a traceless platform for high-efficiency protein delivery into mammalian cells.
- This approach holds significant promise for advancing protein-based therapeutics.


